Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

NH NSE

Key Fundamentals

SmallcapHospitalsHealthcare Services
Market Cap
₹37,312 Cr
Volatility
Moderate
P/E Ratio
45.14
EBITDA
₹1,717 Cr
Return on Equity
17.85%
Debt to Equity
1.29
Book Value
₹222.08
EPS
₹39.47
52W High
₹2,093.3
52W Low
₹1,589

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Narayana Hrudayalaya Ltd insights

50 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

2
  • Company is expected to give good quarter
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24.5%

Weaknesses

2
  • Stock is trading at 8.24 times its book value
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
43.43% ↗
Net Income Growth
2.62% ↗
Cash Flow Change
64.46% ↗
ROE
-18.01% ↘
ROCE
-36.08% ↘
EBITDA Margin (Avg.)
-12.55% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk medium

Narayana Hrudayalaya Ltd is a healthcare services company with a market cap of ₹37,562 crore, trading at a PE of 45.8x and 8.24x book value. The company has delivered strong revenue growth of 60% TTM and maintains a 3-year ROE of 25%, though profit growth has moderated to 9% TTM versus 12% CAGR over 3 years.

Bull Case 8
  • Exceptional TTM revenue growth of 60% signals strong demand and capacity utilization across hospital network
  • Consistent ROE track record of 25% over 3 years and 26% over 5 years indicates efficient capital deployment in a capital-intensive sector
  • Compounded sales CAGR of 25% over 5 years and 17% over 10 years demonstrates sustained long-term top-line expansion
  • 5-year compounded profit CAGR of 155% reflects a dramatic turnaround in profitability from earlier loss-making or low-margin years
  • Stock has delivered 30% CAGR over 5 years and 20% CAGR over 10 years, reflecting consistent long-term value creation
  • Company is expected to deliver a good upcoming quarter based on operational momentum
  • 10-year compounded profit CAGR of 42% shows the business has scaled profitably over a full economic cycle
  • Last year ROE of 21% remains well above cost of equity for most Indian companies, indicating continued value creation
Bear Case 8
  • PE ratio of 45.8x is significantly above the broader market average, leaving limited margin of safety if growth decelerates
  • Price-to-book of 8.24x is expensive for a hospital business with heavy fixed assets, implying high expectations already priced in
  • TTM profit growth of only 9% versus 60% revenue growth suggests significant margin compression or rising costs eating into profitability
  • Potential capitalization of interest costs raises concerns about true operating profitability and asset quality reporting
  • Dividend yield of just 0.25% offers negligible income return, meaning investors are entirely dependent on capital appreciation
  • ROE has declined from 25-26% (3-5 year average) to 21% in the last year, indicating possible margin or efficiency pressure
  • Stock CAGR of 0% over the last 1 year suggests the market has paused rewarding the stock despite continued revenue growth
  • 3-year profit CAGR of only 12% compared to 3-year sales CAGR of 20% indicates operating leverage has not translated proportionally to bottom line

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 19h ago
Headwinds 1
  • Institutional opposition to board appointment Aug 17

    Re-appointment of Dr. Kiran Mazumdar Shaw faced notable opposition from institutional investors at the 26th AGM, though it passed due to strong promoter backing.

Positives 4
  • Record revenue up 44% YoY Jul 24

    FY26 Annual Report shows highest-ever consolidated revenue of ₹78,960.35 million, up 44% YoY, with EBITDA of ₹17,168.91 million.

  • Strong ESG and renewable energy mix Jul 27

    BRSR FY26 reports 39.08% renewable energy mix, ₹80.5 million in savings, carbon neutrality targets achieved with zero safety incidents.

  • ₹4.50 per share dividend approved Aug 17

    Shareholders approved final dividend of ₹4.50 per share at the 26th AGM held on August 14, 2026.

  • Institutional block trades on NSE Aug 04

    Two block trades totalling ~₹57.9 crores executed on NSE at ₹1912.20 and ₹1920.50 per share, reflecting institutional interest.

Neutral 4
  • Multiple investor meets scheduled Aug 07

    NH hosted meetings with American Century (Aug 6), ICICI Securities PMS (Aug 7), and Sundaram MF/Premji Invest via Ambit Capital (Aug 12).

  • Q1FY27 earnings call held Aug 3 Aug 03

    Conference call held at 3:00 PM IST to discuss Q1 FY27 results for quarter ended June 30, 2026; audio recording uploaded.

  • Board met Jul 31 for Q1 results Jul 27

    Board meeting scheduled for July 31 to review and approve Q1 FY27 financial results; no preliminary figures shared.

  • 26th AGM all resolutions passed Aug 17

    All 11 resolutions passed at the 26th AGM including adoption of FY26 financials, dividend, board appointments, and remuneration revisions.

TL;DR: Narayana Hrudayalaya is delivering strong financial momentum with record revenue of ₹78,960 million (up 44% YoY) and healthy EBITDA margins. ESG credentials are solid and institutional interest is evident from block trades and multiple investor meetings. The only notable risk is governance-related, with institutional investors opposing a key board re-appointment. The overall trend is positive with improving fundamentals and growing investor engagement heading into FY27.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1,233
1,305
1,204
1,246
1,306
1,367
1,335
1,475
1,507
1,644
2,151
2,594
2,684
Expenses
963
997
925
955
1,004
1,058
1,027
1,118
1,171
1,243
1,786
2,086
2,216
Operating Profit
271
308
279
291
302
309
307
358
337
401
365
508
468
OPM %
22%
24%
23%
23%
23%
23%
23%
24%
22%
24%
17%
20%
17%
Other Income
15
18
18
26
24
23
18
20
24
24
-29
25
35
Interest
21
23
25
28
34
35
37
41
45
42
65
91
87
Depreciation
59
55
63
65
61
65
70
82
84
87
122
154
156
PBT
206
248
209
225
231
232
219
254
232
296
149
288
260
Tax %
11%
9%
10%
15%
13%
14%
12%
22%
15%
13%
15%
22%
20%
Net Profit
184
227
188
191
202
199
193
197
197
258
127
224
207
EPS in Rs
9
11.09
9.2
9.33
9.85
9.72
9.44
9.65
9.62
12.64
6.2
10.96
10.14
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,364
1,614
1,878
2,281
2,861
3,128
2,583
3,701
4,525
4,890
5,483
7,896
9,072
Expenses
1,236
1,434
1,642
2,064
2,566
2,694
2,394
3,038
3,538
3,722
4,185
6,255
7,330
Operating Profit
128
180
236
217
295
434
189
664
987
1,168
1,298
1,641
1,742
OPM %
9%
11%
13%
10%
10%
14%
7%
18%
22%
24%
24%
21%
19%
Other Income
6
-19
7
18
16
7
21
26
59
73
80
37
56
Interest
45
33
28
55
81
94
82
76
84
112
163
266
285
Depreciation
68
76
80
100
137
186
184
183
210
241
278
448
520
PBT
21
51
135
80
93
161
-56
430
752
888
936
964
993
Tax %
71%
59%
39%
36%
37%
26%
-75%
20%
19%
11%
16%
16%
—
Net Profit
-19
21
83
51
59
119
-14
342
607
790
791
806
817
EPS in Rs
-0.84
1.04
4.06
2.51
2.9
5.82
-0.7
16.73
29.67
38.62
38.66
39.42
39.94
Div. Payout %
0%
0%
0%
0%
35%
17%
0%
6%
8%
10%
12%
11%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
200
204
204
204
204
204
204
204
204
204
204
204
Reserves
568
672
759
831
877
932
916
1,284
1,927
2,679
3,422
4,333
Borrowings
362
258
217
802
813
952
826
723
884
1,627
2,428
5,858
Other Liabilities
241
424
468
692
746
813
833
931
1,155
1,123
1,216
2,088
Total Liabilities
1,371
1,557
1,648
2,529
2,640
2,901
2,779
3,143
4,170
5,633
7,271
12,482
Fixed Assets
913
1,054
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
4,266
7,796
CWIP
20
14
53
35
56
12
20
67
259
514
86
292
Investments
52
87
96
9
17
86
120
132
252
844
1,084
573
Other Assets
385
402
417
637
729
711
678
964
1,323
1,624
1,835
3,822
Total Assets
1,371
1,557
1,648
2,529
2,640
2,901
2,779
3,143
4,170
5,633
7,271
12,482
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
77
174
219
182
279
443
304
485
1,085
1,067
986
1,621
Investing
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
-1,325
-3,648
Financing
140
18
-45
315
-27
-247
-194
-159
88
488
544
2,340
Net Cash Flow
-6
42
28
-22
89
7
-2
59
-4
97
205
313
Free Cash Flow
-15
86
85
-20
129
329
235
235
563
99
-93
753
CFO/OP
78
116
108
100
113
117
133
83
119
99
86
108
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
38
34
30
45
34
31
39
43
35
31
37
30
Inventory Days
56
48
45
56
48
35
32
30
31
44
40
42
Days Payable
146
152
173
200
177
177
221
180
224
214
185
248
Cash Conversion Cycle
-51
-70
-98
-100
-95
-111
-150
-108
-158
-138
-108
-176
Working Capital Days
-30
-12
-11
-10
-10
-22
-38
-16
-25
-30
-17
-19
ROCE %
7%
9%
14%
9%
9%
14%
2%
25%
32%
26%
21%
16%

Shareholding Pattern

As of Jun 2026
Promoters 63.27%
Public 10.93%
FIIs 9.40%
DIIs 9.06%
Others 7.34%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.27%
63.27%
63.27%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
11.60%
0.00%
10.91%
10.01%
9.68%
9.44%
9.66%
10.46%
10.49%
11.10%
9.98%
9.40%
DIIs
14.80%
15.55%
16.15%
14.61%
13.76%
13.43%
16.18%
14.58%
14.14%
11.95%
10.89%
9.46%
9.51%
8.23%
7.90%
8.69%
8.52%
8.09%
7.76%
7.91%
9.15%
9.06%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.01%
0.01%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
4.64%
4.97%
4.85%
5.11%
5.92%
6.87%
5.86%
6.93%
7.10%
7.99%
8.46%
9.04%
10.00%
11.68%
12.13%
11.58%
11.47%
11.18%
11.45%
10.98%
10.64%
10.93%
Others
16.71%
15.63%
15.14%
16.43%
16.46%
15.85%
14.11%
14.64%
14.90%
16.20%
5.20%
17.65%
5.73%
6.23%
6.43%
6.43%
6.50%
6.42%
6.45%
6.73%
6.95%
7.34%
No. of Shareholders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792
1,85,787
2,05,639
2,26,480
2,28,123
2,20,561
2,11,173

Documents

1
Concall - May 2017 May 2017
2
Concall - Jan 2018 Jan 2018
3
Concall - Aug 2020 Aug 2020
4
Concall - Nov 2020 Nov 2020
5
Concall - Oct 2025 Oct 2025

Frequently Asked Questions about Narayana Hrudayalaya Ltd

What does Narayana Hrudayalaya Ltd do?
Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
Where is Narayana Hrudayalaya Ltd (NH) listed?
Narayana Hrudayalaya Ltd is listed on the Indian stock exchanges. It is listed on NSE: NH and BSE: 539551. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Narayana Hrudayalaya Ltd belong to?
Narayana Hrudayalaya Ltd operates in the Healthcare Services sector within the Hospitals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd has a market capitalisation of approximately ₹37312.20 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Narayana Hrudayalaya Ltd?
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 45.14. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Narayana Hrudayalaya Ltd?
Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,589 and a high of ₹2,093.3. This range helps investors understand the stock's price volatility and recent trading levels.
Does Narayana Hrudayalaya Ltd pay dividends?
Yes, Narayana Hrudayalaya Ltd has a dividend yield of 0.25%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd has a Return on Equity (ROE) of 17.85%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Narayana Hrudayalaya Ltd on Tapetide?
On Tapetide, you can view Narayana Hrudayalaya Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Website narayanahealth.org
CEO Dr. Devi Prasad Shetty M.S.
Employees 11,411
Listed 2016-01-06
Face Value ₹ 10
Issued Size 20,43,60,804

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List